dr mary claire haver and glp 1 unPAUSED with Dr. Dr. Mary Claire Haver |

Retatrutide holds no UK marketing authorisation and may only be supplied on a named-patient basis via the MHRA 'Specials' framework, where a registered prescriber takes personal responsibility for its use

Obesity is a chronic disease that benefits from ongoing treatment, she adds

How do I know if I need or can benefit from Chelation Therapy

It is important to note that Ozempic , while chemically identical to Wegovy at lower doses, is FDA-approved only for type 2 diabetes and cardiovascular risk reduction in diabetic patients

Starting GLP-1 treatment can feel like a positive step, but it often comes with a learning curve